State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Peruzzi, Mariangela ^a   De Falco, Elena ^a   Abbate, Antonio ^b   Biondi Zoccai, Giuseppe ^a,b,c   Chimenti, Isotta ^a   Lotrionte, Marzia ^d   Benedetto, Umberto ^e   Delewi, Ronak ^f   Marullo, Antonino G M ^a   Frati, Giacomo ^a,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Eleonora Lonillard Spencer Cenci Foundation   (Italy)

^d Heart Failure and Cardiac Rehabilitation Unit   (Italy)

^e OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC PATIENT; CARDIAC REGENERATIVE THERAPY; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIC HEART DISEASE; JOURNAL IMPACT FACTOR; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; VALIDITY; WEB OF SCIENCE; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASES;

CARDIOVASCULAR DISEASES; CELL- AND TISSUE-BASED THERAPY; HUMANS; REGENERATIVE MEDICINE;

EID: 84934312284     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/613782     Document Type: Review

References (27)

1. E. Braunwald, "Heart failure", JACC: Heart Failure, vol. 1, no. 1, pp. 1-20, 2013.
2. P. C. H. Hsieh, V. F. M. Segers, M. E. Davis et al., "Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury", Nature Medicine, vol. 13, no. 8, pp. 970-974, 2007.
3. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., "Evidence for cardiomyocyte renewal in humans", Science, vol. 324, no. 5923, pp. 98-102, 2009.
4. I. Chimenti, R. R. Smith, T.-S. Li et al., "Relative roles of direct regeneration versus paracrine effects of human cardiospherederived cells transplanted into infarcted mice", Circulation Research, vol. 106, no. 5, pp. 971-980, 2010.
5. I. M. Seropian, S. Toldo, B. W. Van Tassell, and A. Abbate, "Antiinflammatory strategies for ventricular remodeling following St-segment elevation acute myocardial infarction", Journal of the American College of Cardiology, vol. 63, no. 16, pp. 1593-1603, 2014.
6. R. Gaetani, G. Rizzitelli, I. Chimenti et al., "Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application", Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1071-1077, 2010.
7. I. Chimenti, G. Rizzitelli, R. Gaetani et al., "Human cardiosphereseeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs", Biomaterials, vol. 32, no. 35, pp. 9271-9281, 2011.
8. T. I. G. Van Der Spoel, S. J. Jansen Of Lorkeers, P. Agostoni et al., "Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease", Cardiovascular Research, vol. 91, no. 4, pp. 649-658, 2011.
9. B. Assmus, V. Schächinger, C. Teupe et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)", Circulation, vol. 106, no. 24, pp. 3009-3017, 2002.
10. J. Bartunek, M. Vanderheyden, B. Vandekerckhove et al., "Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recentmyocardial infarction: feasibility and safety", Circulation, vol. 112, no. 9, pp. I178-I183, 2005.
11. D. P. Francis, M. Mielewczik, D. Zargaran, and G. D. Cole, "Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions", International Journal of Cardiology, vol. 168, no. 4, pp. 3381-3403, 2013.
12. G. Biondi-Zoccai, Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison, Nova Science, Hauppauge, NY, USA, 2014.
13. N. J. Wald and J. K. Morris, "Teleoanalysis: combining data from different types of study", British Medical Journal, vol. 327, no. 7415, pp. 616-618, 2003.
14. M. C. Shibata, "What is wrong with meta-analysis? The importance of clinical heterogeneity in myocardial regeneration research", International Journal of Clinical Practice, vol. 67, no. 11, pp. 1081-1085, 2013.
15. A. Liberati, D. G. Altman, J. Tetzlaff et al., "The PRISMA statement for reporting systematic reviews andmeta-analyses of studies that evaluate healthcare interventions: explanation and elaboration", British Medical Journal, vol. 339, p. b2700, 2009.
16. B. J. Shea, J. M. Grimshaw, G. A. Wells et al., "Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews", BMC Medical Research Methodology, vol. 7, article 10, 2007.
17. T. Narita and K. Suzuki, "Bone marrow-derived mesenchymal stem cells for the treatment of heart failure", Heart Failure Reviews, vol. 20, no. 1, pp. 53-68, 2015.
18. N. Pavo, S. Charwat, N. Nyolczas et al., "Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences", Journal of Molecular and Cellular Cardiology, vol. 75, pp. 12-24, 2014.
19. C. Fabrizi, F. Angelini, I. Chimenti et al., "Thrombin and thrombin-derived peptides promote proliferation of cardiac progenitor cells in the form of cardiospheres without affecting their differentiation potential", Journal of Biological Regulators and Homeostatic Agents, vol. 25, no. 2, pp. S43-S51, 2011.
20. I. Chimenti, R. Gaetani, E. Forte et al., "Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture", Journal of Cellular and Molecular Medicine, vol. 18, no. 4, pp. 624-634, 2014.
21. I. Chimenti, E. Forte, F. Angelini, E. Messina, and A. Giacomello, "Biochemistry and biology: Heart-to-heart to investigate cardiac progenitor cells", Biochimica et Biophysica Acta-General Subjects, vol. 1830, no. 2, pp. 2459-2469, 2013.
22. I. Chimenti, E. Forte, F. Angelini, A. Giacomello, and E. Messina, "From ontogenesis to regeneration: Learning how to instruct adult cardiac progenitor cells", Progress in Molecular Biology and Translational Science, vol. 111, pp. 109-137, 2012.
23. L. Hartling, B. Vandermeer, and R. M. Fernandes, "Systematic reviews, overviews of reviews and comparative effectiveness reviews: a discussion of approaches to knowledge synthesis", Evidence-Based Child Health: A Cochrane Review Journal, vol. 9, no. 2, pp. 486-494, 2014.
24. A. N. Nowbar, M. Mielewczik, M. Karavassilis et al., "DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis", British Medical Journal, vol. 348, article g2688, 2014.
25. G. Biondi-Zoccai, M. Peruzzi, A. Giordano, and G. Frati, "Transcatheter renal sympathetic denervation for resistant arterial hypertension: when sham brings shame?" Journal of Endovascular Therapy, vol. 21, no. 2, pp. 197-201, 2014.
26. G. G. L. Biondi-Zoccai, M. Lotrionte, A. Abbate et al., "Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study", British Medical Journal, vol. 332, no. 7535, pp. 202-206, 2006.
27. L. Moyé, "DAMASCENE and meta-ecological research: a bridge too far", Circulation Research, vol. 115, no. 5, pp. 484-487, 2014.